BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32966166)

  • 1. Procalcitonin and secondary bacterial infections in COVID-19: association with disease severity and outcomes.
    Vazzana N; Dipaola F; Ognibene S
    Acta Clin Belg; 2022 Apr; 77(2):268-272. PubMed ID: 32966166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
    Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
    J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
    Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
    Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
    Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
    Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or "just" a marker of bacterial coinfection?
    Lugito NPH
    Curr Res Transl Med; 2021 May; 69(2):103289. PubMed ID: 33845428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Level of Procalcitonin in Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
    Heidari-Beni F; Vahedian-Azimi A; Shojaei S; Rahimi-Bashar F; Shahriary A; Johnston TP; Sahebkar A
    Adv Exp Med Biol; 2021; 1321():277-286. PubMed ID: 33656733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
    Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
    BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19.
    Wolfisberg S; Gregoriano C; Schuetz P
    Crit Rev Clin Lab Sci; 2022 Jan; 59(1):54-65. PubMed ID: 34517744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of procalcitonin in cancer patients with coronavirus disease 2019.
    Tiutan T; Wallins JS; Brown S; Gonen M; Korenstein D
    Clin Chem Lab Med; 2023 Jan; 61(2):339-348. PubMed ID: 36367353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection.
    Heer RS; Mandal AK; Kho J; Szawarski P; Csabi P; Grenshaw D; Walker IA; Missouris CG
    Ann Clin Biochem; 2021 Sep; 58(5):520-527. PubMed ID: 34018843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study.
    Atallah NJ; Warren HM; Roberts MB; Elshaboury RH; Bidell MR; Gandhi RG; Adamsick M; Ibrahim MK; Sood R; Bou Zein Eddine S; Cobler-Lichter MJ; Alexander NJ; Timmer KD; Atallah CJ; Viens AL; Panossian VS; Scherer AK; Proctor T; Smartt S; Letourneau AR; Paras ML; Johannes S; Wiemer J; Mansour MK
    PLoS One; 2022; 17(1):e0262342. PubMed ID: 35025929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Procalcitonin Is Positively Associated with the Severity of COVID-19: A Meta-Analysis Based on 10 Cohort Studies.
    Shen Y; Cheng C; Zheng X; Jin Y; Duan G; Chen M; Chen S
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34207689
    [No Abstract]   [Full Text] [Related]  

  • 13. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Bhatnagar N; Annane D; Reinhart K; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Lima SS; Maravić-Stojković V; Verduri A; Cao B; Shehabi Y; Beishuizen A; Jensen JS; Corti C; Van Oers JA; Falsey AR; de Jong E; Oliveira CF; Beghe B; Briel M; Mueller B
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007498. PubMed ID: 29025194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
    Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z
    Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum procalcitonin and C-reactive protein levels as diagnostic markers for distinguishing bacterial infections from lupus flares in systemic lupus erythematosus: A systematic review and meta‑analysis.
    Chen Y; Shen J; Yang H; Xu S; Ma Y; Pan F
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108304. PubMed ID: 34731783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of procalcitonin in predicting risk of mechanical ventilation and mortality among moderate to severe COVID-19 patients.
    Twe CW; Khoo DKY; Law KB; Ahmad Nordin NSB; Sathasivan S; Lim KC; Atikah SK; Syed Badaruddin SNAB; Chidambaram SK
    BMC Infect Dis; 2022 Apr; 22(1):378. PubMed ID: 35428273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum procalcitonin level is independently associated with mechanical ventilation and case-fatality in hospitalized COVID-19-positive US veterans-A potential marker for disease severity.
    Jeyapalina S; Wei G; Stoddard GJ; Sudduth JD; Lundquist M; Huntsman M; Marquez JL; Agarwal JP
    PLoS One; 2023; 18(4):e0284520. PubMed ID: 37068086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin Has Good Accuracy for Prognosis of Critical Condition and Mortality in COVID-19: A Diagnostic Test Accuracy Systematic Review and Meta-analysis.
    Zare ME; Wang Y; Nasir Kansestani A; Almasi A; Zhang J
    Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):557-569. PubMed ID: 33463126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin as a predictor of severity and mortality in a cohort of patients hospitalised with COVID-19.
    Ahmed S; Ahmed ZA; Rashid NH; Mansoor M; Siddiqui I; Jafri L
    Malays J Pathol; 2021 Dec; 43(3):375-380. PubMed ID: 34958058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.